Safety and Efficacy of Sustained Release Dalfampridine in Transverse Myelitis (Re-Launch)

Clinical trial NCT02166346 · COMPLETED

Trial details

NCT number: NCT02166346
Sponsor: Johns Hopkins University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Transverse Myelitis Neuromyelitis Optica Idiopathic Transverse Myelitis Myelitis NOS

Start date: 2014-02-01
Primary completion: 2017-01-08
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.